- SEK3.97bn
- SEK3.85bn
- SEK758.97m
Brief: Cellavision Says Inventory Levels Normalize In Americas
Brief: CellaVision Q2 EBITDA SEK 56 Million
Brief: CellaVision Q1 EBITDA Falls To SEK 35 Mln
Brief: Cellavision BOD Proposes Dividend Of SEK 2.25 Per Share
Brief: CellaVision Q4 EBITDA SEK 48 Million
Brief: CellaVision Q2 EBITDA Up At SEK 61 Mln
Brief: CellaVision Q1 EBITDA Up At SEK 59 million
Brief: CellaVision Proposes Current Chairman Mikael Worning As Chairman Of Board
Brief: CellaVision Q4 EBITDA Grows To SEK 60 Million
Brief: CellaVision CFO Magnus Blixt Leaves Position
Brief: CellaVision Q3 EBITDA Grows To SEK 42 Million
Brief: CellaVision Q2 EBITDA Up At SEK 47.1 Mln
Brief: Cellavision Q1 EBITDA Rises To SEK 46.2 Million
Brief: Cellavision Q4 EBITDA Down At SEK 40.8 Mln
Brief: CellaVision Appoints Simon Østergaard New CEO
Brief: CellaVision Q3 EBITDA Down At SEK 24.6 Mln
CellaVision: Undisputed market leader - Berenberg starts at "buy"
Brief: CellaVision Q2 EBITDA Down At SEK 36.2 Mln
Brief: CellaVision: Zlatko Rihter Leaves Position As CEO